A plurality of terminals are provided on a circuit board of an ink cartridge, and a plurality of lines are formed by contact portions of the plurality of terminals. In a first line among the plurality of lines, contact portions of two terminals for detecting attachment are arranged, and a contact portion of a power supply terminal is arranged therebetween. The first line may be located at a leading side when the ink cartridge is moved in a predetermined direction and is mounted on a printing device, or the first line may be the line closest to an opening of an ink supply port, or the first line may be the line closest to an ink supply needle.

Disclosed are methods and preparation useful for reducing fat at a targeted area(s) on a human. The preparation comprises paeoniflorin as an active ingredient. The method may be accompanied by the application of the paeoniflorin preparation to an area of the body in which fat reduction is desired. The method and the preparation are effective for reducing targeted fat deposits at various anatomical sites of the body, such as the midsection("love handles"), jowls, hips, arms, thighs and buttocks area.

A method forms a relatively stable ammonium nitrate composite material. The method includes (a) blending ammonium nitrate with an average particle diameter greater than about 1 mm and a substantially non-oxidizing compound in fine particle form; and (b) reducing the average size of said ammonium nitrate granules in the presence of the non-oxidizing compound in fine particle form to produce a substantially homogeneous blend of ammonium nitrate and the non-oxidizing compound having an average particle diameter of about 1 to about 1,000 m to form a substantially non-explosive powder.

A shop-assembled solar receiver heat exchanger having an arrangement of heat transfer surfaces and a vertical steam/water separator structurally and fluidically interconnected thereto. A vertical support structure is provided to support the vertical separator and the heat transfer surfaces. The vertical support structure is bottom supported, while the vertical steam/water separator and heat exchanger heat transfer surfaces are top supported from the vertical support structure. The vertical support structure provides structural support and rigidity for the heat exchanger and a means by which the heat exchanger can be picked up and lifted for placement at a desired location. A fabrication/transport/lifting fixture is provided which facilitates fabrication, assembly, transportation and erection of the heat exchanger from the shop to the field. The fixture supports two trunnion shafts attached to the support structure of the receiver Lifting lugs would be located on the top end of the support structure.

Heterophasic polypropylene resin having an MFR (2.16 kg, 230°C) of more than 40 g/10 min, determined according to ISO 1133 comprising a propylene homo- or copolymer matrix (A) and an ethylene-propylene rubber phase (B) dispersed within the matrix, wherein the heterophasic polypropylene resin has a fraction insoluble in p-xylene at 25°C (XCU) with an intrinsic viscosity of 1.2 dl/g or less, determined according to DIN EN ISO 1628-1 and -3, the fraction insoluble in p-xylene at 25°C (XCU) being composed of propylene monomer units in an amount of at least 95 wt.-%, and a fraction soluble in p-xylene at 25°C (XCS), having an intrinsic viscosity of 2.0 to 3.5 dl/g, determined according to DIN EN ISO 1628-1 and -3 and being composed of propylene monomer units in an amount of 50 wt. -% or more, and having a glass transition temperature Tg as measured by DSC according to ISO 6721-7 at a compression moulded sample consisting of the XCS fraction in the range of - 42 to - 30°C.

The present invention relates to a bispecific single chain antibody molecule comprising a first binding domain capable of binding to an epitope of human and non-chimpanzee primate CD3 epsilon chain, wherein the epitope is part of an amino acid sequence comprised in the group consisting of SEQ ID NOs. 2, 4, 6, and 8, and a second binding domain capable of binding to prostate-specific membrane antigen (PSMA). The invention also provides nucleic acids encoding said bispecific single chain antibody molecule as well as vectors and host cells and a process for its production. The invention further relates to pharmaceutical compositions comprising said bispecific single chain antibody molecule and medical uses of said bispecific single chain antibody molecule.

A system and method for sharing of the single lit fibre, originating from the aggregation equipment and terminating at the service delivery ports of the ONU (Optical Network Unit) or vice versa, by creating plurality of virtually secured physical mediums within the single fibre and dedicating ports in the ONU to each such virtually secured physical medium, for to and fro transport of the respective services, including building management services, building automation services, security & surveillance services and community services and/or Home automation and remote management services voice, video and data services, based on IP, TDM/ ATM/ VoIP and RF technologies, of multiple service providers while allowing each service provider to manage, configure and administer their respective, services, contents and end devices without change in their proprietary network management software and allowing it to carry out billing and provide necessary support services to end consumer independently.

The can (10; 10A; 10B; 10C) for the extemporaneous preparation of beverages by extraction and/or infusion comprises a first chamber (12) intended to collect the final beverage, a second chamber (14) containing a drinkable liquid and a filtering device (16) containing a substance able to produce the required beverage by extraction and/or infusion. The can is foreseen to be put onto a heating source after opening the can lid (18; 18A, 18B; 18C) and operating the filtering device (16) by the user. The lid (18; 18A, 18B; 18C) comprises: an outer rim portion (22; 22B) intended to remain fixed to the can lateral wall (20) when opening the can; an inner removable portion (24; 24A; 24B; 24C) intended to be ripped in order to open the can; and a predetermined breaking line (34) separating said inner removable portion (24; 24A; 24B; 24C) from said outer rim portion (22; 22B). The breaking line (34) is provided in an annular portion (28; 28A; 28B; 28C) forming part of the lid (18; 18A, 18B; 18C) and made of plastic material. The outer part (32; 32B) of the annular portion (28; 28A; 28B; 28C) is part of the outer rim portion (22; 22B) while the inner part thereof (24; 24A; 24B; 24C) is part of the inner removable portion (24; 24A; 24B; 24C).

The present invention is directed to a pharmaceutical submicron suspension and a method of forming the submicron suspension. The submicron suspension is useful for delivery of relatively hydrophobic and/or low solubility therapeutic agent. The submicron suspension and method of forming the submicron suspension typically employ a polymeric material that aids in preventing aggregation of the therapeutic agent.

The present invention relates to an inserter for an intrauterine system comprising a handle (3),and an insertion tube (6) having a first end and a second end, and being arranged in connection with the handle. The inserter is characterized in that the first end of the insertion tube (6) comprises at least one frame slot for receiving a frame of the intrauterine system.The invention also relates to a kit comprising an inserter according to the present invention and an intrauterine system, wherein the intrauterine system (1) comprises a therapeutic component (1b)and a continuous, closed frame(1a), the therapeutic component (1b) being connected to the frame(1a) at least one point, and therapeutic component (1b) of the intrauterine system (1) is at least mainly arranged inside the first end of the insertion tube (6) and the frame (1a) of the intrauterine system (1) is at least mainly arranged outside the first end of the insertion tube (6).